Cancerous Tumor Articles & Analysis
42 articles found
These chemokines protein allows researchers to study the functional dynamics of chemokine-receptor interactions in controlled environments, facilitating the development of targeted therapies for a range of diseases, including cancer, autoimmune disorders, and chronic inflammatory conditions. One of the most significant applications lies in cancer immunotherapy. ...
This technique has proven invaluable in the diagnosis of genetic disorders and certain cancers. On the other hand, IHC is focused on identifying specific proteins within a tissue sample using antibodies. ...
Anti-Tumor APIs: Pioneering Cancer Treatment Anti-tumor Active Pharmaceutical Ingredients (APIs) are vital in today's medical landscape, addressing one of the most pressing health challenges: cancer. These APIs form the foundation of various therapeutic strategies aimed at inhibiting or destroying tumor cells in ...
This phenomenon offers a remarkable opportunity in cancer therapy. Tumors often exhibit mutations that can be exploited for targeted treatments. ...
Understanding Drug Resistance Drug resistance occurs when cancer cells or pathogens evolve mechanisms that render them less susceptible to the effects of therapeutic agents. Various factors contribute to this phenomenon, including genetic mutations, alterations in drug targets, enhanced drug efflux, and changes in metabolic pathways. In cancer, the heterogeneity ...
What are Colorectal Cancer Cell Lines? Colorectal cancer cell lines are cultured cells derived from tumor tissues of patients diagnosed with colorectal cancer. ...
Among the most promising strategies in this endeavor are the use of tumor models for breast cancer and the development of customized antibody-drug conjugates (ADCs). ...
Discover how matched tumor-normal sequencing can help clinical researchers detect the somatic origin of variants with certainty. In the era of precision oncology, it has become increasingly common for patients diagnosed with cancer to undergo tumor sequencing. Identifying the mutations that make up a tumor’s genomic ...
Additionally, to delve deeper into cancer pathogenesis, Alfa Cytology also provides in vivo and in vitro cancer model customization services, providing versatile models that simulate diverse cancer types and stages. ...
ESMO updated its recommendations for NGS in advanced cancers this year, urging broader use of NGS in additional cancer types and the inclusion of tumor-agnostic biomarkers. The ESMO Precision Medicine Working Group (PMWG) first published its recommendations for when to use next-generation sequencing (NGS) in routine practice for patients ...
Compared to other solid tumors, pancreatic cancer (PC) lacks effective therapy with poor outcomes. ...
Alfa Cytology has announced tumor models customization service for pancreatic cancer research. ...
Cancer is a complex disease that involves a delicate interplay between the tumor cells and the host immune system. ...
Cancer is a complex disease that involves a delicate interplay between the tumor cells and the host immune system. ...
Applications of fluorescent liposomes Fluorescent liposomes are proving valuable in various research areas, including: Cancer research: Studying tumor targeting and drug delivery strategies for improved cancer therapy. ...
For instance, it is widely used to diagnose abnormal cells, such as those found in cancerous tumors, by using specific molecular markers to characterize specific cellular events, such as proliferation or cell death (apoptosis). ...
Given its multifaceted contribution to tumor advancement as an emerging immune checkpoint, CD73 stands out as a promising target for cancer treatment. ...
Antibody-drug conjugates (ADCs), as emerging anticancer drugs, can deliver highly cytotoxic molecules directly to cancer cells to kill them. ADC is a monoclonal antibody covalently bound to cytotoxic chemical substances (payload) through linker. ...
Interestingly, FAUST findings in combination with single cell RNA sequencing data and follow up functional assays led Prilic et al. to identify one type of T regulatory cell– a unique population expressing IL-1R1 and ICOS– that localized to solid tumors and suppressed immune defenses. Moreover, the Hutch researchers compared their findings in head and neck solid ...
For example, most drug developers target the same dozens of genes when developing cancer drugs. If the KRAS gene is found to play a central role in many solid tumor cancers, then companies will search for chemicals that can neutralize KRAS proteins as a potential treatment method. ...